
ORKA Valuation
Oruka Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
ORKA Relative Valuation
ORKA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ORKA is overvalued; if below, it's undervalued.
Historical Valuation
Oruka Therapeutics Inc (ORKA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.02. The fair price of Oruka Therapeutics Inc (ORKA) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:14.23
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.50
P/B
Median3y
1.08
Median5y
1.08
-15.96
FCF Yield
Median3y
-18.60
Median5y
-18.60
Competitors Valuation Multiple
The average P/S ratio for ORKA's competitors is 1.79, providing a benchmark for relative valuation. Oruka Therapeutics Inc Corp (ORKA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

RWAY
Runway Growth Finance Corp
11.050
USD
-1.07%

CYH
Community Health Systems Inc
2.900
USD
-25.26%

CYD
China Yuchai International Ltd
23.530
USD
-1.88%

YRD
Yiren Digital Ltd
6.360
USD
+0.47%

SNDA
Sonida Senior Living Inc
24.520
USD
-1.92%

SOHU
Sohu.com Ltd
15.490
USD
+0.45%

AHG
Akso Health Group
1.760
USD
-8.33%

ACTG
Acacia Research Corp
3.780
USD
-0.26%

SHYF
Shyft Group Inc
12.545
USD
-0.80%

DCGO
DocGo Inc
1.450
USD
-7.05%
FAQ

Is Oruka Therapeutics Inc (ORKA) currently overvalued or undervalued?
Oruka Therapeutics Inc (ORKA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.02. The fair price of Oruka Therapeutics Inc (ORKA) is between to according to relative valuation methord.

What is Oruka Therapeutics Inc (ORKA) fair value?

How does ORKA's valuation metrics compare to the industry average?

What is the current P/B ratio for Oruka Therapeutics Inc (ORKA) as of Jul 25 2025?

What is the current FCF Yield for Oruka Therapeutics Inc (ORKA) as of Jul 25 2025?

What is the current Forward P/E ratio for Oruka Therapeutics Inc (ORKA) as of Jul 25 2025?
